Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies
dc.rights.license | open | |
hal.structure.identifier | Groupe de Recherche en Economie Théorique et Appliquée [GREThA] | |
dc.contributor.author | GORRY, Philippe
IDREF: 136806775 | |
hal.structure.identifier | Centre de recherche en économie et management [CREM] | |
dc.contributor.author | USECHE, Diego | |
dc.contributor.editor | Ernst R.Berndt | |
dc.contributor.editor | Dana P. Goldman | |
dc.contributor.editor | John Rowe | |
dc.date.accessioned | 2020-02-17T11:18:01Z | |
dc.date.available | 2020-02-17T11:18:01Z | |
dc.date.issued | 2019 | |
dc.identifier.isbn | 9780226611068 | |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/761 | |
dc.language.iso | en | |
dc.publisher | University of Chicago Press | |
dc.source.title | Economic Dimensions of Personalized and Precision Medicine | |
dc.title.en | Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies | |
dc.type | Chapitre d'ouvrage | |
dc.identifier.doi | 10.7208/chicago/9780226611235.003.0011 | |
dc.subject.hal | Économie et finance quantitative [q-fin] | |
bordeaux.page | 305-334 | |
bordeaux.institution | Université de Bordeaux | |
hal.identifier | hal-02152424 | |
hal.version | 1 | |
hal.origin.link | https://hal.archives-ouvertes.fr//hal-02152424v1 | |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.btitle=Economic%20Dimensions%20of%20Personalized%20and%20Precision%20Medicine&rft.date=2019&rft.spage=305-334&rft.epage=305-334&rft.au=GORRY,%20Philippe&USECHE,%20Diego&rft.isbn=9780226611068&rft.genre=unknown |
Fichier(s) constituant ce document
Fichiers | Taille | Format | Vue |
---|---|---|---|
Il n'y a pas de fichiers associés à ce document. |